JUNSNasdaqPharmaceutical PreparationsFiscal year ends December 31
JUPITER NEUROSCIENCES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$2.75−0.15 (-5.34%)
Close on Oct 19, 2026
- Market cap
- $1.53M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$116.53 (−97.69%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
JUPITER NEUROSCIENCES, INC. reported revenue of $21.80K for fiscal 2025.
Revenue
$21.80K
FY2025
Operating income
-$9.81M
TTM Q2 2026
EPS, diluted
-$18.89
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- $1.53M
- P/E ratio
- –
- Price to sales
- 70.35
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $21.80K
- Net income
- -$9.20M
- EPS, diluted
- -$18.89
- Book value per share
- -$0.66
- Diluted shares
- 1M
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
-$9.81M
Net income
-$9.20M
EPS, diluted
-$18.89
Reported periodTrailing twelve months